Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -0.3x - -0.4x | -0.4x |
| Selected Fwd P/E Multiple | -6.6x - -7.3x | -7.0x |
| Fair Value | €4.89 - €5.41 | €5.15 |
| Upside | 71.1% - 89.1% | 80.1% |
| Benchmarks | - | Full Ticker |
| DocGo Inc. | - | NasdaqCM:DCGO |
| Option Care Health, Inc. | - | NasdaqGS:OPCH |
| Addus HomeCare Corporation | - | NasdaqGS:ADUS |
| American Well Corporation | - | NYSE:AMWL |
| Integra LifeSciences Holdings Corporation | - | NasdaqGS:IART |
| ModivCare Inc. | - | DB:PRF0 |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| DCGO | OPCH | ADUS | AMWL | IART | PRF0 | |||
| NasdaqCM:DCGO | NasdaqGS:OPCH | NasdaqGS:ADUS | NYSE:AMWL | NasdaqGS:IART | DB:PRF0 | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | 23.3% | NM- | NM- | NM- | ||
| 3Y CAGR | -5.6% | 14.8% | 17.7% | NM- | NM- | NM- | ||
| Latest Twelve Months | -103.0% | -21.6% | 20.3% | 55.7% | -172.0% | -2.9% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 1.6% | 3.4% | 5.3% | -120.1% | 7.0% | -2.0% | ||
| Prior Fiscal Year | 1.1% | 6.2% | 5.9% | -260.6% | 4.4% | -7.4% | ||
| Latest Fiscal Year | 3.2% | 4.2% | 6.4% | -81.8% | -0.4% | -7.2% | ||
| Latest Twelve Months | -0.1% | 4.1% | 6.5% | -59.1% | -1.8% | -8.3% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 8.9x | 15.7x | 15.8x | 0.8x | 8.2x | 11.6x | ||
| Price / LTM Sales | 0.3x | 1.0x | 1.7x | 0.4x | 0.6x | 0.0x | ||
| LTM P/E Ratio | -246.0x | 24.2x | 26.2x | -0.7x | -31.1x | -0.2x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -246.0x | -0.7x | 26.2x | |||||
| Historical LTM P/E Ratio | -22.5x | -0.9x | 90.2x | |||||
| Selected P/E Multiple | -0.3x | -0.4x | -0.4x | |||||
| (x) LTM Net Income | (229) | (229) | (229) | |||||
| (=) Equity Value | 80 | 84 | 89 | |||||
| (/) Shares Outstanding | 14.4 | 14.4 | 14.4 | |||||
| Implied Value Range | 5.59 | 5.88 | 6.18 | |||||
| FX Rate: USD/EUR | 1.2 | 1.2 | 1.2 | Market Price | ||||
| Implied Value Range (Trading Cur) | 4.85 | 5.11 | 5.36 | 2.86 | ||||
| Upside / (Downside) | 69.6% | 78.6% | 87.5% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | DCGO | OPCH | ADUS | AMWL | IART | PRF0 | |
| Value of Common Equity | 158 | 5,163 | 2,066 | 105 | 901 | 47 | |
| (/) Shares Outstanding | 99.1 | 163.7 | 18.2 | 15.6 | 77.7 | 14.4 | |
| Implied Stock Price | 1.59 | 31.53 | 113.79 | 6.75 | 11.60 | 3.29 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.15 | |
| Implied Stock Price (Trading Cur) | 1.59 | 31.53 | 113.79 | 6.75 | 11.60 | 2.86 | |
| Trading Currency | USD | USD | USD | USD | USD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.15 | |